Lumanity

Overview

Healthcare consultancy formed in 2022 by Arsenal Capital Partners from the merger of Cello Health, BresMed, Guidemark Health, Cyan Health, and Zipher Medical Affairs. Strong in value demonstration, HEOR modeling, value dossiers, and HTA submissions.

Notable

Supports 80+ market launches and 50+ payer submissions across ~20 countries annually; built via Arsenal Capital's value demonstration acquisition campaign (2020-2022).

Key services

HEOR & economic modeling
Value dossiers & HTA submissions
Market access strategy
Evidence generation
Medical affairs & communications

Subcategories

HEOR
Value Communications
Hta Submissions
Payer Strategy
Medical Communications
Medical Affairs Consulting
HEOR Market Access
Medical Writing

Verified Reviews

No verified reviews yet — are you a customer of Lumanity? Share your experience in a short, confidential interview.

Share your experience

Sources

https://www.prnewswire.com/news-releases/introducing-lumanity---an-organization-dedicated-to-accelerating-and-optimizing-access-to-medical-advances-301501260.html
https://lumanity.com/cello-health-and-bresmed-join-forces-to-support-value-demonstration-and-optimize-patient-access-for-new-biopharma-therapies/
https://www.arsenalcapital.com/news/introducing-lumanity-an-organization-dedicated-to-accelerating-and-optimizing-access-to-medical-advances
https://lumanity.com/arsenals-value-demonstration-business-acquires-zipher-medical-affairs/